课题基金 / 基金详情

C3, CR1, CRRY: INTERACTIONS, HOMEOSTASIS AND TRANSLATIONAL IMPLICATIONS

C3, CR1, CRRY: INTERACTIONS, HOMEOSTASIS AND TRANSLATIONAL IMPLICATIONS
C3、CR1、CRRY:相互作用、稳态和翻译意义
批准号:
8038297
负责人:
John Atkinson
金额:
$37.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 2014-02-28
关键词:
Abdominal Aortic AneurysmActive SitesAddressAdherenceAgeAge related macular degenerationAlzheimer&aposs DiseaseAmyloid ProteinsAnimal ModelAntigen-Antibody ComplexApoptoticApplications GrantsAreaAtherosclerosisAutoantibodiesBindingBinding SitesBiological AssayBiologyBlood VesselsBrainCD46 AntigenCD55 AntigensCellsChronicClinicalCloningComplementComplement 3 ConvertaseComplement 3bComplement 3b ReceptorsComplement 3cComplement 4bComplement ActivationComplement Factor BComplement Factor DComplement ReceptorComplexDepositionDiseaseDisease AssociationDisease modelDrusenEngineeringFeedbackGarbageGenetic PolymorphismGenetic VariationGlomerulonephritisGoalsGoutGrantHealthHemolysisHemolytic-Uremic SyndromeHomeostasisHumanImmuneImmune responseImmune systemInflammationInvadedInvestigationJointsKidney TransplantationKnockout MiceLaboratoriesLeadLectinLigand BindingLipidsLipofuscinLupusMediatingMembraneMembranoproliferative GlomerulonephritisMicrobeModelingMonitorMusMutagenesisMutationMyocardial InfarctionNatural ImmunityNecrosisOrganParasitesPathologicPathway interactionsPigmentsProperdinProteinsPublicationsRegulationRelative (related person)ReproductionRetinaRiskRoleSiteStrokeStructureStructure-Activity RelationshipSurface Plasmon ResonanceSystemSystemic Lupus ErythematosusT-LymphocyteTechnologyTissuesTransplantationUratearmbasecofactorcomplement C3 precursorcomplement systemdecay accelerationgenetic regulatory proteinglycosylationhuman diseasein vivoinjuredinsightmanmicrobialmicroorganismmouse modelnovelpathogenpreventprotein structure functionpublic health relevancereceptorreceptor structure functionresearch studywasting

项目摘要

项目成果

John Atkinson的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):补体系统是先天免疫的主要参与者,也是体液免疫反应的效应器。补体系统通过天然抗体、凝集素和替代途径(AP),特别是AP的反馈环,激活微生物并改变自身。目标是损伤、凋亡和坏死的细胞、堆积的碎片和微生物病原体。随着年龄的增长,脂质沉积在血管壁(动脉粥样硬化),尿酸盐沉积在关节(痛风),淀粉样蛋白沉积在大脑(阿尔茨海默病-AD),脂褐素色素沉积在视网膜(老年性黄斑变性-AMD)。这些身体的“废物”或“垃圾”会成为补体激活的底物,导致慢性炎症。因此,调节补体系统,特别是扩增环,对于免疫稳态和防止重要器官的异常激活至关重要。这项拨款提案的目的是建立在补体的关键C3b片段与受体和调节器相互作用的先前贡献的基础上,并通过以下方式进一步探索其作为组装反馈回路的核心的作用:1)评估C3b与其调节器和受体的相互作用,目的是表征C3中易患非典型溶血性尿毒症综合征(AHUS)的新的杂合突变,以及C3中与年龄相关的黄斑变性和肾移植存活相关的C3的多态;2)进一步定义补体受体1型(CR1;CD35)的结构和功能,包括分析最近发现的与人类疾病相关的突变;3)利用一种新产生的动物模型,Crry-Single基因敲除(SKO)小鼠和Crry小鼠,检查体内补体调节,重点是AP反馈环的动态平衡,并评估AP介导病理后果的人类疾病模型。提出的实验的一个基本假设是,AP不断地翻转细胞,从而充当对外来代理人和改变的自我的监视系统。与公共健康相关:先天免疫系统对微生物和受损的宿主组织做出反应。它与许多常见的人类疾病有关,包括大脑中变化的蛋白质沉积(阿尔茨海默病)、血管壁中的脂质(心脏病发作和中风)以及视网膜中的色素(老年性黄斑变性)。这些重要器官的慢性炎症是不可取的。此外,包括疟疾寄生虫在内的许多病原体利用先天免疫因子入侵、感染和伤害,疟疾寄生虫是世界上大部分地区的主要健康风险。这些研究将加强我们对先天免疫系统如何参与一些最常见和致命的人类疾病的理解。
英文摘要
DESCRIPTION (provided by applicant): The complement system is a major player in innate immunity and an effector arm of the humoral immune response. Through natural Abs, lectins and the alternative pathway (AP), especially the AP's feedback loop, the complement system activates on microbes and altered self. Injured, apoptotic and necrotic cells, accumulations of debris, and microbial pathogens are targets. As we age, lipids deposit in blood vessel walls (atherosclerosis), urate in joints (gout), amyloid proteins in the brain (Alzheimer's disease - AD) and lipofuscin pigments (drusen) in the retina (age-related macular degeneration - AMD). These body "wastes" or "garbage" become substrates for complement activation, leading to chronic inflammation. Thus, regulation of the complement system, particularly the amplification loop, is critical to immune homeostasis and to prevent undesirable activation in vital organs. The goal of this grant proposal is to build on prior contributions relating to interactions of the complement's key C3b fragment with receptors and regulators and to further explore its role as a nidus for assembling the feedback loop by: 1) assessing C3b interactions with its regulators and receptors, with a goal of characterizing novel heterozygous mutations in C3 that predispose to atypical hemolytic uremic syndrome (aHUS) and on a polymorphism in C3 associated with age-related macular degeneration and renal transplant survival; 2) further defining the structure and function of complement receptor type one (CR1; CD35), including analyzing recently identified mutations associated with human disease; and 3) employing a newly generated animal model, the Crry-single knockout (SKO) mouse, and the Crry mouse to examine complement regulation in vivo with a focus on homeostasis of the AP's feedback loop and to assess models of human disease in which the AP mediates pathologic consequences. An underlying hypothesis for proposed experiments is that the AP is continuously turning over on cells and thereby serves as a surveillance system for foreign agents and altered self. PUBLIC HEALTH RELEVANCE: The innate immune system responds to microorganisms and damaged host tissue. It is involved in many common human diseases featuring deposition of altered proteins in the brain (Alzheimer Disease), lipids in vessel walls (heart attacks and strokes) and pigments in the retina (age-related macular degeneration). Chronic inflammation in such vital organs is undesirable. Also, many pathogens including the malarial parasite, a major health risk for much of the world, take advantage of innate immune players to invade, infect, and injure. These studies will enhance our understanding of how the innate immune system participates in some of the most common and lethal diseases of man.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Scleroderma Renal Crisis as a Genetic Complementopathy
  • 批准号:
    10159866
  • 项目类别:
  • 资助金额:
    $16.83万
  • 财政年份:
    2020
  • 负责人:
    John Atkinson
  • 依托单位:
Defining the Complosome in Human Cells, Tissues and Disease States
  • 批准号:
    10597611
  • 项目类别:
  • 资助金额:
    $39.37万
  • 财政年份:
    2020
  • 负责人:
    John Atkinson
  • 依托单位:
Defining the Complosome in Human Cells, Tissues and Disease States
  • 批准号:
    10375425
  • 项目类别:
  • 资助金额:
    $39.38万
  • 财政年份:
    2020
  • 负责人:
    John Atkinson
  • 依托单位:
Complement Activation Signatures in Systemic Lupus Erythematosus: Castle Study
  • 批准号:
    9317177
  • 项目类别:
  • 资助金额:
    $20.13万
  • 财政年份:
    2017
  • 负责人:
    John Atkinson
  • 依托单位:
海外基金